Zobrazeno 1 - 10
of 266
pro vyhledávání: '"Asio, J."'
Autor:
Inzaule, S. C., Jordan, M. R., Cournil, Amandine, Giron-Callejas, A., Avila-Rios, S., Mulenga, L., Ssemwanga, D., Asio, J., Diop-Ndiaye, H., Niasse-Traore, F., Nhan, D. T., Dat, V. Q., Aghokeng Fobang, Avelin, Billong, S., Cham, F., Doherty, M., Bertagnolio, S., Acquired HIV Drug Resistance Survey Team
Objective: We aimed to assess the frequency of tenofovir (TDF) resistance in people failing tenofovir/lamivudine or emtricitabine (XTC)/nonnucleotide reverse-transcriptase inhibitor-based first-line antiretroviral treatment (ART) using data from 15 n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______932::adf258d1b45eff2fd4f9ab3d8c1fde49
http://www.documentation.ird.fr/hor/fdi:010080919
http://www.documentation.ird.fr/hor/fdi:010080919
Autor:
Watera C; Uganda Virus Research Institute (UVRI), Entebbe, Uganda., Ssemwanga D; Uganda Virus Research Institute (UVRI), Entebbe, Uganda.; Medical Research Council (MRC)/UVRI and London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, Uganda., Namayanja G; United States Centers for Disease Control and Prevention (CDC) Division of Global HIV and TB, Kampala, Uganda., Asio J; Uganda Virus Research Institute (UVRI), Entebbe, Uganda., Lutalo T; Uganda Virus Research Institute (UVRI), Entebbe, Uganda., Namale A; United States Centers for Disease Control and Prevention (CDC) Division of Global HIV and TB, Kampala, Uganda., Sanyu G; Uganda Virus Research Institute (UVRI), Entebbe, Uganda., Ssewanyana I; Central Public Health Laboratories (CPHL), Kampala, Uganda., Gonzalez-Salazar JF; Medical Research Council (MRC)/UVRI and London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, Uganda., Nazziwa J; Medical Research Council (MRC)/UVRI and London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, Uganda., Nanyonjo M; Medical Research Council (MRC)/UVRI and London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, Uganda., Raizes E; United States Centers for Disease Control and Prevention Division of Global HIV and TB, Atlanta, GA, USA., Kabuga U; Uganda Virus Research Institute (UVRI), Entebbe, Uganda., Mwangi C; United States Centers for Disease Control and Prevention (CDC) Division of Global HIV and TB, Kampala, Uganda., Kirungi W; Ministry of Health, AIDS Control Programme, Kampala, Uganda., Musinguzi J; Ministry of Health, AIDS Control Programme, Kampala, Uganda., Mugagga K; World Health Organization (WHO), Kampala, Uganda., Mbidde EK; Uganda Virus Research Institute (UVRI), Entebbe, Uganda., Kaleebu P; Uganda Virus Research Institute (UVRI), Entebbe, Uganda.; Medical Research Council (MRC)/UVRI and London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, Uganda.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Aug 12; Vol. 76 (9), pp. 2407-2414.
Autor:
Obispo, Kristoffer Paul C.1 obispo.kristofferpaul@gordoncollege.edu.ph, Paguio, Darwin P.1, Amarille, Anna Theresa M.1
Publikováno v:
International Journal of Multidisciplinary: Applied Business & Education Research. Feb2023, Vol. 4 Issue 2, p677-685. 9p.
Autor:
Gregson, J, Tang, M, Ndembi, N, Hamers, Rl, Marconi, Vc, Brooks, K, Theys, K, Arruda, M, Garcia, F, Monge, S, Kanki, Pj, Kumarasamy, N, Kerschberger, B, Mor, O, Charpentier, C, Todesco, E, Rokx, C, Gras, L, Halvas, Ek, Sunpath, H, Carlo, Dd, Antinori, A, Andreoni, M, Latini, A, Mussini, C, Aghokeng, A, Sonnerborg, A, Neogi, U, Fessel, Wj, Agolory, S, Yang, C, Blanco, Jl, Juma, Jm, Smit, E, Schmidt, D, Watera, C, Asio, J, Kirungi, W, Tostevin, A, Clumeck, N, Goedhals, D, Bester, Pa, Sabin, C, Mukui, I, Santoro, M, Perno, Cf, Hunt, G, Morris, L, Pillay, D, Schulter, E, Reyes-Teran, G, Romero, K, Avila-Rios, S, Sirivichayakul, S, Ruxrungtham, K, Mekprasan, S, Dunn, D, Kaleebu, P, Raizes, E, Kantor, R, Gupta, Rk, Rhee, S, Shafer, Rw, de Wit, Tfr, Diero, L, Camacho, R, Gunthard, Hf, Hoffmann, Cj, Di Carlo, D, El-Hay, T, van Vuuren, C, de Oliveira, T, Murakami-Ogasawara, A
Publikováno v:
The Lancet. Infectious Diseases
Summary Background Antiretroviral therapy (ART) is crucial for controlling HIV-1 infection through wide-scale treatment as prevention and pre-exposure prophylaxis (PrEP). Potent tenofovir disoproxil fumarate-containing regimens are increasingly used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e49b76ec436755cb4c45f012d68c8419
https://hdl.handle.net/10668/18894
https://hdl.handle.net/10668/18894
Autor:
Sivalingam, Krishna Moorthy1 (AUTHOR) drkrishna.micro@wsu.edu.et, Choramo, Israel Solomon2 (AUTHOR), Chutulo, Eyob Chukalo1 (AUTHOR)
Publikováno v:
BMC Research Notes. 7/9/2024, Vol. 17 Issue 1, p1-8. 8p.
Autor:
Inzaule SC; Department of HIV/Hepatitis/STI, World Health Organization, Geneva, Switzerland., Jordan MR; Tufts University School of Medicine, Boston, Massachusetts, USA., Cournil A; Unité Mixte Internationale 233, Institut de Recherche pour le Développement, U1175-INSERM, University of Montpellier, Montpellier, France., Girón-Callejas A; Universidad del Valle de Guatemala, Guatemala City, Guatemala., Avila-Rios S; National Institute of Respiratory Diseases, Research Center in Infectious Diseases, Mexico City, Mexico., Mulenga L; National HIV Treatment and Care Programme, Ministry of Health, Lusaka, Zambia., Ssemwanga D; Uganda Virus Research Institute, Entebbe, Uganda., Asio J; Uganda Virus Research Institute, Entebbe, Uganda., Diop-Ndiaye H; Laboratoire de Bactériologie-Virologie, CHNU Aristide le Dantec., Niasse-Traore F; Conseil National de Lutte contre le SIDA, Dakar, Senegal., Nhan DT; Viet Nam Authority for HIV/ADS Prevention and Control., Dat VQ; Department of Infectious Diseases, Hanoi Medical University, Hanoi, Vietnam., Aghokeng AF; UMR IRD 224 - CNRS 5290 - MIVEGEC - Université de Montpellier, Montpellier, France., Billong S; National HIV Drug Resistance Surveillance and Prevention Working Group (HIVDR-WG), National AIDS Control Committee, Yaoundé, Cameroon., Cham F; Regional Office for Africa, World Health Organization, Brazzaville, Congo., Doherty M; Department of HIV/Hepatitis/STI, World Health Organization, Geneva, Switzerland., Bertagnolio S; Department of HIV/Hepatitis/STI, World Health Organization, Geneva, Switzerland.
Publikováno v:
AIDS (London, England) [AIDS] 2020 Nov 01; Vol. 34 (13), pp. 1965-1969.
Autor:
Gregson, J, Tang, M, Ndembi, N, Hamers, R, Marconi, V, Brooks, K, Theys, K, Arruda, M, Garcia, F, Monge, S, Kanki, P, Kumarasamy, N, Kerschberger, B, Mor, O, Charpentier, C, Todesco, E, Rokx, C, Gras, L, Halvas, E, Sunpath, H, Carlo, D, Antinori, A, Andreoni, M, Latini, A, Mussini, C, Aghokeng, A, Sonnerborg, A, Neogi, U, Fessel, W, Agolory, S, Yang, C, Blanco, J, Juma, J, Smit, E, Schmidt, D, Watera, C, Asio, J, Kirungi, W, Tostevin, A, Clumeck, N, Goedhals, D, Bester, P, Sabin, C, Mukui, I, Santoro, M, Perno, C, Hunt, G, Morris, L, Camacho, R, Pillay, D, Schulter, E, Reyes-Terán, G, Romero, K, Avila-Rios, S, Sirivichayakul, S, Ruxrungtham, K, Mekprasan, S, Dunn, D, Kaleebu, P, Raizes, E, Kantor, R, Shafer, R, Gupta, R, Rhee, S, De Wit, T, Diero, L, Günthard, H, Hoffmann, C, Di Carlo, D
Publikováno v:
Lancet Infectious Diseases. 16(5)
Background Antiretroviral therapy (ART) is crucial for controlling HIV-1 infection through wide-scale treatment as prevention and pre-exposure prophylaxis (PrEP). Potent tenofovir disoproxil fumarate-containing regimens are increasingly used to treat
Autor:
Ssemwanga D; Medical Research Council/Uganda Virus Research Institute (UVRI), and London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, Uganda.; Uganda Virus Research Institute, Entebbe, Uganda., Asio J; Uganda Virus Research Institute, Entebbe, Uganda., Watera C; Uganda Virus Research Institute, Entebbe, Uganda., Nannyonjo M; Medical Research Council/Uganda Virus Research Institute (UVRI), and London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, Uganda., Nassolo F; Medical Research Council/Uganda Virus Research Institute (UVRI), and London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, Uganda., Lunkuse S; Medical Research Council/Uganda Virus Research Institute (UVRI), and London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, Uganda., Salazar-Gonzalez JF; Medical Research Council/Uganda Virus Research Institute (UVRI), and London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, Uganda., Salazar MG; Medical Research Council/Uganda Virus Research Institute (UVRI), and London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, Uganda., Sanyu G; Uganda Virus Research Institute, Entebbe, Uganda., Lutalo T; Uganda Virus Research Institute, Entebbe, Uganda., Kabuga U; Uganda Virus Research Institute, Entebbe, Uganda., Ssewanyana I; Central Public Health Laboratories, Kampala, Uganda., Namatovu F; Central Public Health Laboratories, Kampala, Uganda., Namayanja G; United States Centers for Disease Control and Prevention, Kampala, Uganda., Namale A; United States Centers for Disease Control and Prevention, Kampala, Uganda., Raizes E; United States Centers for Disease Control and Prevention, Atlanta, GA, USA., Kaggwa M; World Health Organization, Kampala, Uganda., Namuwenge N; AIDS Control Programme, Ministry of Health, Kampala, Uganda., Kirungi W; AIDS Control Programme, Ministry of Health, Kampala, Uganda., Katongole-Mbidde E; Uganda Virus Research Institute, Entebbe, Uganda., Kaleebu P; Medical Research Council/Uganda Virus Research Institute (UVRI), and London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, Uganda.; Uganda Virus Research Institute, Entebbe, Uganda.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2020 May 01; Vol. 75 (5), pp. 1280-1289.
Autor:
Asio J; Uganda Virus Research Institute, Entebbe, Uganda., Watera C; Uganda Virus Research Institute, Entebbe, Uganda., Namuwenge N; Uganda AIDS Control Programme, Ministry of Health, Kampala, Uganda., Kirungi W; Uganda AIDS Control Programme, Ministry of Health, Kampala, Uganda., Musinguzi J; Uganda AIDS Control Programme, Ministry of Health, Kampala, Uganda., Mugagga K; Malaria and Non Communicable Diseases, World Health Organisation-Uganda Country office, Kampala, Uganda., Busobozi R; Uganda Virus Research Institute, Entebbe, Uganda., Tusiime BJ; Uganda Virus Research Institute, Entebbe, Uganda., Lutalo T; Uganda Virus Research Institute, Entebbe, Uganda., Mbidde EK; Uganda Virus Research Institute, Entebbe, Uganda., Kaleebu P; Uganda Virus Research Institute, Entebbe, Uganda.; Basic Sciences Programme, Medical Research Council (MRC)/Uganda Virus Research Institute (UVRI) and London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, Uganda.; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Publikováno v:
PloS one [PLoS One] 2020 Apr 14; Vol. 15 (4), pp. e0230451. Date of Electronic Publication: 2020 Apr 14 (Print Publication: 2020).
Autor:
Qingyun Li1, Zhen Tian1, Zihao (Michael) Li2 michaelli@hkapa.edu, Jie Han3, Zhongyang Zhang1, Yanjun Zhang4
Publikováno v:
SAGE Open. Apr-Jun2024, Vol. 14 Issue 2, p1-14. 14p.